Philips Stellarex News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Philips stellarex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Philips Stellarex Today - Breaking & Trending Today

Royal Philips: Five-year patient-level meta-analysis of ILLUMENATE EU RCT and Pivotal study results confirms safety profile of Philips Stellarex .035 low-dose Drug-Coated Balloon

Royal Philips: Five-year patient-level meta-analysis of ILLUMENATE EU RCT and Pivotal study results confirms safety profile of Philips Stellarex .035 low-dose Drug-Coated Balloon
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Noord Holland , Philips Enduracoat , William Gray , Stellarex Dcbs , Philips Stellarex , Chris Landon , Lankenau Heart Institute , Philips Global Press Office , Drug Coated Balloon , Senior Vice President , General Manager Image Guided Therapy Devices , Philips Drug Coated Balloon , Image Guided Therapy , Death Following Application , Paclitaxel Coated Balloons , Femoropopliteal Artery , Systematic Review , Randomized Controlled , Cardiovascular Interventions , நூற்த் ஹாலண்ட் , வில்லியம் சாம்பல் , கிறிஸ் லேண்டன் , லான்கேனௌ இதயம் நிறுவனம் , பிலிப்ஸ் உலகளாவிய ப்ரெஸ் அலுவலகம் , மருந்து பூசப்பட்ட பலூன் , மூத்தவர் துணை ப்ரெஸிடெஂட் ,

Royal Philips: Five-year ILLUMENATE EU RCT and Pivotal study results confirm safety profile of Philips Stellarex .035 low-dose drug-coated balloon

(2)
January 25, 2021
Two major randomized controlled trials (RCTs) show no difference in mortality between patients treated with the Philips Stellarex drug-coated balloon (DCB) and those treated with percutaneous angioplasty (PTA), the current standard of care
Amsterdam, the Netherlands -
Royal Philips).
The ILLUMENATE EU RCT and ILLUMENATE Pivotal RCT together comprised approximately 600 patients in Europe and the U.S. After five years, the ILLUMENATE EU RCT showed 19.3% mortality among patients treated with the Stellarex DCB compared to 19.4% mortality for those treated with PTA. The five-year results for the ILLUMENATE Pivotal study also show no statistically significant difference among patients treated with the Stellarex DCB (21.2%) compared to those treated with PTA (20.2%). Both studies had a high vital status follow-up compliance, with the status of over 90% of patients known. ....

Noord Holland , Philips Enduracoat , Philips Stellarex , Chris Landon , Marianne Brodmann , University Of Graz , Philips Global Press Office , Medical University , Senior Vice President , General Manager Image Guided Therapy Devices , Image Guided Therapy , நூற்த் ஹாலண்ட் , கிறிஸ் லேண்டன் , பல்கலைக்கழகம் ஆஃப் க்ர்யாஸ் , பிலிப்ஸ் உலகளாவிய ப்ரெஸ் அலுவலகம் , மருத்துவ பல்கலைக்கழகம் , மூத்தவர் துணை ப்ரெஸிடெஂட் , ஜநரல் மேலாளர் படம் வழிகாட்டப்பட்டது சிகிச்சை சாதனங்கள் , படம் வழிகாட்டப்பட்டது சிகிச்சை ,

Five-year ILLUMENATE EU RCT and Pivotal study results confirm safety profile of Philips ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Five-year ILLUMENATE EU RCT and Pivotal study results confirm safety profile of Philips .
Royal PhilipsJanuary 25, 2021 GMT
January 25, 2021
Two major randomized controlled trials (RCTs) show no difference in mortality between patients treated with the Philips Stellarex drug-coated balloon (DCB) and those treated with percutaneous angioplasty (PTA), the current standard of care
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the final, five-year results of two major randomized controlled trials (RCTs) that show no difference in all-cause mortality between patients treated with the Stellarex drug-coated balloon (DCB) and those treated with percutaneous angioplasty (PTA), the current standard of care. Moreover, the studies showed no difference in mortality between the Stellarex DCB and PTA at eve ....

Noord Holland , Philips Enduracoat , Philips Stellarex , Chris Landon , Marianne Brodmann , University Of Graz , Philips Global Press Office , Royal Philips , Interventional Course , Medical University , Senior Vice President , General Manager Image Guided Therapy Devices , Image Guided Therapy , Medical Technology , Western Europe , Medical Research , Diagnosis And Treatment , Globe Newswire , நூற்த் ஹாலண்ட் , கிறிஸ் லேண்டன் , பல்கலைக்கழகம் ஆஃப் க்ர்யாஸ் , பிலிப்ஸ் உலகளாவிய ப்ரெஸ் அலுவலகம் , அரச பிலிப்ஸ் , தலையீடு நிச்சயமாக , மருத்துவ பல்கலைக்கழகம் , மூத்தவர் துணை ப்ரெஸிடெஂட் ,